• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Ampco-Pittsburgh Corporation (Amendment)

    11/28/22 4:06:00 PM ET
    $AP
    Fluid Controls
    Industrials
    Get the next $AP alert in real time by email
    SC 13D/A 1 d426807dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 7)*

     

     

    Ampco-Pittsburgh Corporation

    (Name of Issuer)

    Common Stock, par value $1.00 per share

    (Title of Class of Securities)

    032037 10 3

    (CUSIP Number)

    Jennifer L. Gloff

    Chief Financial Officer and Treasurer

    The Louis Berkman Investment Company

    600 Grant Street, Suite 3230

    Pittsburgh, Pennsylvania 15219-2704

    (412) 652-9480

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    November 21, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 032037 10 3

     

      1    

      NAMES OF REPORTING PERSONS:

      The Louis Berkman Investment Company

     

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY:

     

      4  

      SOURCE OF FUNDS (SEE INSTRUCTIONS):

     

      WC, BK

      5  

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e):

     

      ☐

      6  

      CITIZENSHIP OR PLACE OF ORGANIZATION:

     

      Ohio

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7     

      SOLE VOTING POWER:

     

      4,196,219 (including Common Shares underlying the Warrants. See Item 5)

         8   

      SHARED VOTING POWER:

     

      0

         9   

      SOLE DISPOSITIVE POWER:

     

      4,196,219 (including Common Shares underlying the Warrants. See Item 5)

       10   

      SHARED DISPOSITIVE POWER:

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

     

      4,196,219 (including Common Shares underlying the Warrants. See Item 5)

    12  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):

     

      ☐

    13  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):

     

      20.4%

    14  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):

     

      CO


    CUSIP No. 032037 10 3

    This Amendment No. 7 to Schedule 13D (“Amendment”) amends and supplements, the Schedule 13D filed on April 28, 2006 by The Louis Berkman Investment Company, an Ohio corporation (“LBIC”), with respect to the Common Stock, par value $1.00 per share (“Common Shares”), of the Ampco-Pittsburgh Corporation (the “Issuer”), as amended by Amendment No. 1 thereto filed on July 5, 2007, Amendment No. 2 thereto filed on December 26, 2007, Amendment No. 3 thereto filed on February 2, 2009, Amendment No. 4 thereto filed on April 10, 2018, Amendment No. 5 thereto filed on September 22, 2020, and Amendment No. 6 (the “Sixth Amendment”) thereto filed on March 1, 2022.

    Item 3. Source and Amount of Funds or Other Consideration

    Item 3 of this Schedule 13D is hereby supplemented as follows:

    The source of the funds for LBIC’s purchase of the Common Shares (as further described in Item 4) consisted of $1,390,042.08 borrowed by LBIC under a previously established working capital line of credit with First Republic Bank.

    Item 4. Purpose of Transaction

    Item 4 of this Schedule 13D is hereby amended as follows:

    This Amendment is being filed to report the purchase by LBIC of 551,604 common shares of the Issuer (“Common Shares”) for $2.50 per whole Common Share on November 21, 2022 for investment purposes.

    Except as set forth herein, the Reporting Person filing this Amendment has no plans or proposals that relate to or would result in any of the actions or events set forth in paragraphs (a) through (j) of Item 4 of Schedule 13D.

    Item 5. Interest in Securities of the Issuer

    Item 5 of this Schedule 13D is hereby supplemented as follows:

    (a)–(b). The responses of the Reporting Person with respect to Rows 7, 8, 9, 10, 11 and 13 of the cover pages to this Schedule 13D are incorporated herein by reference. Of the 4,196,219 common shares reported as beneficially owned by the Reporting Person, 1,161,427 are pursuant to Warrants to purchase common shares held by the Reporting Person which are exercisable prior to their expiration on August 1, 2025. See Item 4 of the Sixth Amendment, which is incorporated herein by reference. Share percentage calculations in this Schedule are based on 19,403,519 Common Shares outstanding as of November 9, 2022 as reported in the Issuer’s Quarterly Report filed with the SEC on November 14, 2022, plus 1,161,427 Common Shares which will be receivable by the Reporting Person if and when it exercises all of the Warrants held by it. The 20,564,946 shares outstanding used to calculate the Reporting Person’s 20.4% ownership assumes no other shareholder exercises their Warrants.

    As of the date of this report, Mr. Laurence Paul, a Director and President of LBIC, beneficially owns 33,456 Common Shares of the Issuer (excluding Common Shares owned by LBIC). Mr. Laurence Paul has sole voting and dispositive powers over these 33,456 Common Shares.

    As of the date of this report, Mr. Stephen Paul, a Director of the Issuer and a Director and President of LBIC, beneficially owns 87,308 Common Shares of the Issuer (excluding Common Shares owned by LBIC). Mr. Stephen Paul has sole voting and dispositive powers over these 87,308 Common Shares.

    (c) Other than as described herein, there have been no other transactions in the Issuer’s securities by the Reporting Person during the past sixty days.


    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: November 28, 2022

     

    THE LOUIS BERKMAN INVESTMENT COMPANY

    /s/ Jennifer L. Gloff

    By: Jennifer L. Gloff
    Its: Chief Financial Officer and Treasurer
    Get the next $AP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Ampco-Pittsburgh Corporation (NYSE: AP) Announces First Quarter 2025 Results

      Net income attributable to Ampco-Pittsburgh of $1.1 million in Q1 2025, a $3.8 million year-over-year increase Earnings per common share of $0.06, up $0.20 versus prior year Adjusted EBITDA of $8.8 million in Q1 2025 compared to $5.1 million in Q1 2024 Ampco-Pittsburgh Corporation (NYSE:AP) reported net sales of $104.3 million for the three months ended March 31, 2025, compared to $110.2 million for the three months ended March 31, 2024. Both the Forged and Cast Engineered Products ("FCEP") segment and the Air and Liquid Processing ("ALP") segment had lower sales year-over-year. Despite lower sales, the Corporation reported income from operations of $3.9 million for the three months

      5/12/25 4:05:00 PM ET
      $AP
      Fluid Controls
      Industrials
    • Ampco-Pittsburgh Schedules First Quarter 2025 Earnings Conference Call

      Ampco-Pittsburgh Corporation (NYSE:AP) will hold a conference call on Tuesday, May 13, 2025, at 10:30 a.m. Eastern Time (ET) to discuss its financial results for the first quarter ended March 31, 2025. If you would like to participate in the conference call, please register using the link below or by dialing 1-844-308-3408 at least five minutes before the 10:30 a.m. ET start time. We encourage participants to pre-register for the conference call using the following link. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call

      5/5/25 4:04:00 PM ET
      $AP
      Fluid Controls
      Industrials
    • Ardent Health Appoints Robert DeMichiei to Board of Directors

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

      4/3/25 5:27:00 PM ET
      $AP
      $ARDT
      $HCAT
      $WAY
      Fluid Controls
      Industrials
      Hospital/Nursing Management
      Health Care